All posts tagged "Vivance"

Kempharm (KMPH) Shareholders Blinded by Short Term Greed Versus Solid Long Term Outlook

The ADHD market is over $10B yearly in the US. Last week, Kempharm (NASDAQ: KMPH) announced a very positive restructuring of their...